Company News

Search Articles

With Renewed Growth, Empire Genomics Hires New CEO

Empire Genomics has brought on a new leadership team with deep experience in the molecular genomics industry. The Amherst-based company has chosen Andy Watson as its chief executive officer and Anthony Scarpello as chief commercialization officer. Watson previously ran genomics startup Genturi while Scarpello was promoted from vice president of sales and business development. Longtime Empire Genomics CEO Anthony Johnson resigned last year amidst changes for the company, which moved out of its downtown Buffalo headquarters and settled into larger space at 1000 Youngs Road in Amherst.February 20th, 2019

Empire Genomics Appoints New Leadership and Relocates Headquarters to Support Growing Demand from Clinical Laboratories Around the World

Empire Genomics Inc., the premier global provider of clinical and custom labeled molecular probes, today announced the appointments of Andy Watson as Chief Executive Officer and Anthony Scarpello to Chief Commercialization Officer, and the opening of its new headquarters in Williamsville, NY. After a successful and profitable 2018, the company is now focused on increasing operational efficiencies, driving its long-term commercial growth strategy and enabling more customers to advance biomarker research, accelerate diagnosis and improve treatment options for individual patients battling cancer and other complex diseases.February 19th, 2019